These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17023544)

  • 1. Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002.
    Werny DM; Saraiya M; Gregg EW
    Am J Epidemiol; 2006 Nov; 164(10):978-83. PubMed ID: 17023544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
    Welch HG; Schwartz LM; Woloshin S
    J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001-2002 National Health and Nutrition Examination Survey.
    Singer EA; Palapattu GS; van Wijngaarden E
    Cancer; 2008 Oct; 113(8):2053-7. PubMed ID: 18780337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prostate-specific antigen levels in men with type 2 diabetes.
    Fukui M; Tanaka M; Kadono M; Imai S; Hasegawa G; Yoshikawa T; Nakamura N
    Diabetes Care; 2008 May; 31(5):930-1. PubMed ID: 18276768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004.
    Werny DM; Thompson T; Saraiya M; Freedman D; Kottiri BJ; German RR; Wener M
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):70-6. PubMed ID: 17179487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and screening PSA levels among men undergoing an annual physical exam.
    Rundle A; Neugut AI
    Prostate; 2008 Mar; 68(4):373-80. PubMed ID: 18189231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing level of prostate-specific antigen and prostate cancer risk factors among 193 men examined in screening procedure.
    Opalińska E; Michalak A; Stoma F; Latalski M; Goniewicz M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):57-63. PubMed ID: 15323167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening.
    Porter MP; Stanford JL; Lange PH
    Prostate; 2006 Jul; 66(10):1044-51. PubMed ID: 16598738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
    Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
    Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of body mass index and prostate-specific antigen in a population-based study.
    Baillargeon J; Pollock BH; Kristal AR; Bradshaw P; Hernandez J; Basler J; Higgins B; Lynch S; Rozanski T; Troyer D; Thompson I
    Cancer; 2005 Mar; 103(5):1092-5. PubMed ID: 15668913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum prostate-specific antigen level, liver function tests and lipid profile in healthy men.
    Han JH; Chang IH; Ahn SH; Kwon OJ; Bang SH; Choi NY; Park SW; Myung SC; Kim HW
    BJU Int; 2008 Nov; 102(9):1097-101. PubMed ID: 18522630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and risk of prostate cancer in a prospective cohort of US men.
    Rodriguez C; Patel AV; Mondul AM; Jacobs EJ; Thun MJ; Calle EE
    Am J Epidemiol; 2005 Jan; 161(2):147-52. PubMed ID: 15632264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
    Ulmert D; Serio AM; O'Brien MF; Becker C; Eastham JA; Scardino PT; Björk T; Berglund G; Vickers AJ; Lilja H
    J Clin Oncol; 2008 Feb; 26(6):835-41. PubMed ID: 18281654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale study of clinical impact of PSA velocity: long-term PSA kinetics as method of differentiating men with from those without prostate cancer.
    Berger AP; Deibl M; Strasak A; Bektic J; Pelzer AE; Klocker H; Steiner H; Fritsche G; Bartsch G; Horninger W
    Urology; 2007 Jan; 69(1):134-8. PubMed ID: 17270635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.
    Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C
    BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline prostate-specific antigen level and risk of prostate cancer and prostate-specific mortality: diagnosis is dependent on the intensity of investigation.
    Connolly D; Black A; Gavin A; Keane PF; Murray LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):271-8. PubMed ID: 18250343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
    Hutterer G; Perrotte P; Gallina A; Walz J; Jeldres C; Traumann M; Suardi N; Saad F; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI
    Eur J Cancer; 2007 May; 43(7):1180-7. PubMed ID: 17292604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.